发明名称 |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
摘要 |
<p>Disclosed are methods of intravenous administration of nanoparticulate drug formulations to a mammal to avoid adverse hemodynamic effects: by reducing the rate and concentration of the nanoparticles in the formulations; or by pretreating the subject with histamine; or by pretreating the subject with a desensitizing amount of the nanoparticulate drug formulations.</p> |
申请公布号 |
EP2275094(A3) |
申请公布日期 |
2012.08.29 |
申请号 |
EP20100181619 |
申请日期 |
1996.09.25 |
申请人 |
ELAN PHARMA INTERNATIONAL LIMITED |
发明人 |
DE GARAVILLA, LAWRENCE;LIVERSIDGE, ELAINE, M.;LIVERSIDGE, GARY, G. |
分类号 |
A61K9/14;A61K9/16;A61K9/127;A61K45/06;A61K47/30;A61K49/04;A61K49/18;B82Y5/00 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|